首页> 外文期刊>British Journal of Applied Science and Technology >Toxicological and Protective Effect of AqueousStem Bark Extract of Khaya senegalensis (ASBEKS)on Liver of Experimental Rat
【24h】

Toxicological and Protective Effect of AqueousStem Bark Extract of Khaya senegalensis (ASBEKS)on Liver of Experimental Rat

机译:塞内加尔海藻(ASBEKS)干树皮提取物对实验大鼠肝脏的毒理和保护作用

获取原文
           

摘要

The use of medicinal plant to prevent and or cure liver problems is a practice not peculiar to developing countries. This research work evaluated oral LD50 and hepatoprotective properties of aqueous stem bark extract of Khaya senegalensis (ASBEKS) in rats. The rats were grouped into six groups (GI – GVI) of six rats each. GI served as normal control, GII served as CCl4 control, GIII was administered with only ASBEKS at a dose of 2.10 g/kg body weight per day for two weeks, while GIV, GV and GVI were administered with the extract at a dose of 1.05 g/kg, 2.10 g/kg and 3.15 g/kg respectively for two weeks. At the end of the first week, three rats from each group were selected and rats in groups II, IV, V and VI were attempted to be induced with liver damage using 120 mg of CCl4 administered subcutaneously. The animals were euthanized after 24 hours of CCl4 administration and liver function indices (ALT, AST, ALP, total protein, Albumin and Bilirubin) were assayed. The treatment was continued for the remaining three animals from each group, and at the end of second week of extract administration, liver damage was induced to groups II, IV, V and VI using 120 mg of CCl4 as above. The oral LD50 of ASBEKS was found to be 4200 mg/kg body weight, which is slightly toxic according to standard scale of toxicity. A significant decrease (p<0.05) was observed in the mean serum ALT, AST and ALP of GROUP IV animals treated for one week when compared to GII. This shows that ASBEKS at a dose of 1.05 g/kg daily for one week may protect hepatocytes against CCl4 hepatotoxicity. Contrary observation was recorded at higher doses of the extract for one week and two weeks of administration. A significant increase in liver function indices was recorded in GV and GVI as compared to GII in one and two weeks of extract administration, it may therefore speculate the aggravating effects of the extract to CCl4 hepatotoxicity. The finding of the study reaffirmed the LD50 established and conclusion. The hepatoprotective and hepatotoxicity effects of the plant could be due to its secondary metabolites contents and it should be used with caution in the management/ treatment of aliments.
机译:使用药用植物预防和/或治疗肝脏问题是发展中国家所不习惯的做法。这项研究工作评估了大鼠塞内加尔海草(ASBEKS)的水干树皮提取物的口服LD50和保肝性能。将大鼠分为六组(GI – GVI),每组六只。 GI作为正常对照,GII作为CCl4对照,GIII仅以每天2.10 g / kg体重的剂量服用ASBEKS,持续两周,而GIV,GV和GVI则以1.05的剂量服用提取物g / kg,2.10 g / kg和3.15 g / kg,持续两周。在第一周结束时,从每组中选择三只大鼠,并试图通过皮下施用120mg CCl 4来诱导II,IV,V和VI组的大鼠肝损伤。给予CCl4 24小时后,对动物实施安乐死并测定肝功能指数(ALT,AST,ALP,总蛋白,白蛋白和胆红素)。对于每组的其余三只动物继续治疗,在提取物施用的第二周结束时,如上所述使用120mg CCl 4诱导肝损伤II,IV,V和VI组。发现ASBEKS的口服LD50为4200 mg / kg体重,根据标准毒性标准,其毒性很小。与GII相比,治疗一周的GROUP IV动物的平均血清ALT,AST和ALP显着降低(p <0.05)。这表明ASBEKS每天1.05 g / kg的剂量持续一周,可以保护肝细胞免受CCl4肝毒性的侵害。在给药的一周和两周中以较高剂量的提取物记录了相反的观察。与提取物施用一到两周的GII相比,GV和GVI中肝功能指数显着增加,因此可以推测出提取物对CCl4肝毒性的加重作用。研究的结果重申了LD50的建立和结论。植物的肝脏保护作用和肝毒性作用可能是由于其次生代谢产物的含量,在饮食管理/治疗中应谨慎使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号